Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Walkty

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23)Melissa McCracken, Andrew Walkty, Heather J Adam, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolatesAndrew Walkty, David A Boyd, Denise Gravel, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitalsAndrew J Denisuik, James A Karlowsky, Tyler Denisuik, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance studyJames A Karlowsky, Philippe R S Lagacé-Wiens, Patricia J Simner, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2021
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18James A Karlowsky, Andrew Walkty, Alyssa R Golden, et al.
Diagnostic Microbiology and Infectious Disease|January 15, 2019
Frequency of 16S ribosomal RNA methyltransferase detection among Escherichia coli and Klebsiella pneumoniae clinical isolates obtained from patients in Canadian hospitals (CANWARD, 2013-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
American Journal of Clinical Dermatology|June 25, 2008
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporinGeorge G Zhanel, Ashley Lam, Frank Schweizer, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2019
Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
CMAJ Open|December 27, 2016
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015)Andrew Walkty, James A Karlowsky, Heather J Adam, et al.
Msphere|May 20, 2021
Emergence of <i>Morganellaceae</i> Harboring <i>bla</i><sub>IMP-27</sub> Metalloenzyme in CanadaDavid A Boyd, Laura F Mataseje, Tanis Dingle, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23)Melissa McCracken, Andrew Walkty, Heather J Adam, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolatesAndrew Walkty, David A Boyd, Denise Gravel, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitalsAndrew J Denisuik, James A Karlowsky, Tyler Denisuik, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance studyJames A Karlowsky, Philippe R S Lagacé-Wiens, Patricia J Simner, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2021
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18James A Karlowsky, Andrew Walkty, Alyssa R Golden, et al.
Diagnostic Microbiology and Infectious Disease|January 15, 2019
Frequency of 16S ribosomal RNA methyltransferase detection among Escherichia coli and Klebsiella pneumoniae clinical isolates obtained from patients in Canadian hospitals (CANWARD, 2013-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
American Journal of Clinical Dermatology|June 25, 2008
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporinGeorge G Zhanel, Ashley Lam, Frank Schweizer, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2019
Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
CMAJ Open|December 27, 2016
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015)Andrew Walkty, James A Karlowsky, Heather J Adam, et al.
Msphere|May 20, 2021
Emergence of <i>Morganellaceae</i> Harboring <i>bla</i><sub>IMP-27</sub> Metalloenzyme in CanadaDavid A Boyd, Laura F Mataseje, Tanis Dingle, et al.
Pageof 11